Plasminogen activator inhibitor-1 expression is regulated by the angiotensin type 1 receptor in vivo

Kidney International

Volumn 58, Issue 1, 2000, Pages 251-259

  Nakamura, Shinya ^a   Nakamura, Ikuko ^a   Ma, Lijun ^a   Vaughan, Douglas E ^a   Fogo, Agnes B ^a,b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Blood pressure; Extracellular matrix; Plasmin plasminogen activator system; Renin angiotensin system

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; HYDRALAZINE; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; IN VIVO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; RAT; RECEPTOR BLOCKING; REGULATORY MECHANISM; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 0033935808     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2000.00160.x     Document Type: Article

References (31)

1. 1. HARRIS RC, CHENG HF: The intrarenal renin-angiotensin system: A paracrine system for the local control of renal function separate from the systemic axis. Exp Nephrol 4(Suppl 1):2-7, 1996
2. 2. UNGER T, CULMAN J, GOHLKE P: Angiotensin II receptor blockade and end-organ protection: Pharmacological rationale and evidence. J Hypertens (Suppl 16):S3-S9, 1998
3. 3. WOLF G: Angiotensin II is involved in the progression of renal disease: Importance of non-hemodynamic mechanisms. Nephrologie 19:451-456, 1998
4. 4. ARDAILLOU R: Angiotensin II receptors. J Am Soc Nephrol 10(Suppl 11):S30-S39, 1999
5. 5. VAN LEEUWEN RT, KOL A, ANDREOTTI F, KLUFT C, MASERI A, SPERTI G: Angiotensin II increases plasminogen activator inhibitor type 1 and tissue-type plasminogen activator messenger RNA in cultured rat aortic smooth muscle cells. Circulation 90:362-368, 1994
6. 6. KERINS DM, HAO Q, VAUGHAN DE: Angiotensin induction of PAI-1 expression in endothelial cells is mediated by the hexapeptide angiotensin IV. J Clin Invest 96:2515-2520, 1995
7. 7. VAUGHAN DE, LAZOS SA, TONG K: Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells. J Clin Invest 95:995-1001, 1995
8. 8. FEENER EP, NORTHRUP JM, AIELLO LP, KING GL: Angiotensin II induces plasminogen activator inhibitor-1 and -2 expression in vascular endothelial and smooth muscle cells. J Clin Invest 95:1353-1362, 1995
9. 9. CHUA CC, HAMDY RC, CHUA BH: Angiotensin II induces TIMP-1 production in rat heart endothelial cells. Biochim Biophys Acta 1311:175-180, 1996
10. 10. VASSALLI JD, SAPPINO AP, BELIN D: The plasminogen activator/plasmin system. J Clin Invest 88:1067-1072, 1991
11. 11. ALEXANDER CM, WERB Z: Proteinases and extracellular matrix remodeling. Curr Opin Cell Biol 1:974-982, 1989
12. 12. EITZMAN DT, MCCOY RD, ZHENG X, FAY WP, SHEN T, GINSBURG D, SIMON RH: Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene. J Clin Invest 97:232-237, 1996
13. 13. FOGO AB, VAUGHAN DE: Compound interest: ACE and PAI-1 polymorphisms and risk of thrombosis and fibrosis. Kidney Int 54:1765-1766, 1998
14. 14. OIKAWA T, FREEMAN M, LO W, VAUGHAN DE, FOGO A: Modulation of plasminogen activator inhibitor-1 in vivo: A new mechanism for the anti-fibrotic effect of renin-angiotensin inhibition. Kidney Int 51:164-172, 1997
15. 15. THORNTON AJ, BRUZDZINSKI CJ, RAPER SE, GELEHRTER TD: Plasminogen activator inhibitor-1 is an immediate early response gene in regenerating rat liver. Cancer Res 54:1337-1343, 1994
16. 16. KASISKE BL, KALIL RS, MA JZ, LIAO M, KEANE WF: Effect of antihypertensive therapy on the kidney in patients with diabetes: A meta-regression analysis. Ann Intern Med 118:129-138, 1993
17. 17. KOHARA K, MIKAMI H, OKUDA N, HIGAKI J, OGIHARA T: Angiotensin blockade and the progression of renal damage in the spontaneously hypertensive rat. Hypertension 21:975-979, 1993
18. 18. MATSUSAKA T, HYMES J, ICHIKAWA I: Angiotensin in progressive renal diseases: Theory and practice. J Am Soc Nephrol 7:2025-2043, 1996
19. 19. JOHNSON RJ, FLOEGE J, COUSER WG, ALPERS CE: Role of platelet-derived growth factor in glomerular disease. J Am Soc Nephrol 4:119-128, 1993
20. 20. KETTELER M, NOBLE NA, BORDER WA: Transforming growth factor-β and angiotensin II: The missing link from glomerular hyperfiltration to glomerulosclerosis? Annu Rev Physiol 57:279-295, 1995
21. 21. HAHN AW, REGENASS S, KERN F, BUHLER FR, RESINK TJ: Expression of soluble and insoluble fibronectin in rat aorta: Effects of angiotensin II and endothelin-1. Biochem Biophys Res Commun 192:189-197, 1993
22. 22. DENNLER S, ITOH S, VIVIEN D, TEN DIJKE P, HUET S, GAUTHIER JM: Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J 17:3091-3100, 1998
23. 23. KAGAMI S, KUHARA T, OKADA K, KURODA Y, BORDER WA, NOBLE NA: Dual effects of angiotensin II on the plasminogen/plasmin system in rat mesangial cells. Kidney Int 51:664-671, 1997
24. 24. BROWN NJ, VAUGHAN DE: The renin-angiotensin and fibrinolytic systems: Co-conspirators in the pathogenesis of ischemic cardiovascular disease. Trends Cardiovasc Med 6:239-243, 1996
25. 25. HAMDAN AD, QUIST WC, GAGNE JB, FEENER EP: Angiotensin-converting enzyme inhibition suppresses plasminogen activator inhibitor-1 expression in the neointima of balloon-injured rat aorta. Circulation 93:1073-1078, 1996
26. 26. RIDKER PM, GABOURY CL, CONLIN PR, SEELY EW, WILLIAMS GH, VAUGHAN DE: Stimulation of plasminogen activator inhibitor in vivo by infusion of angiotensin II: Evidence of a potential interaction between the renin-angiotensin system and fibrinolytic function. Circulation 87:1969-1973, 1993
27. 27. BROWN NJ, AGIRBASLI MA, WILLIAMS GH, LITCHFIELD WR, VAUGHAN DE: Effect of activation and inhibition of the renin-angiotensin system on plasma PAI-1. Hypertension 32:965-971, 1998
28. 28. VAUGHAN DE, ROULEAU JL, RIDKER PM, ARNOLD JM, MENAPACE FJ, PFEFFER MA: Effects of ramipril on plasma fibrinolytic balance in patients with acute anterior myocardial infarction: Heart Study Investigators. Circulation 96:442-447, 1997
29. 29. SCHNEIDERMAN J, SAWDEY MS, KEETON MR, BORDIN GM, BERNSTEIN EF, DILLEY RB, LOSKUTOFF DJ: Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries. Proc Natl Acad Sci USA 89:6998-7002, 1992
30. 30. HAMSTEN A, WIMAN B, DE FAIRE U, BLOMBACK M: Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. N Engl J Med 313:1557-1563, 1985
31. 31. SCHNEIDER DJ, NORDT TK, SOBEL BE: Attenuated fibrinolysis and accelerated atherogenesis in type II diabetic patients. Diabetes 42:1-7, 1993